health π¬ Pharma needs to tag biologics vs synthetics
The Centre plans a regulatory update to make pharmaceutical companies clearly label biologics versus synthetic drugs. This change applies to drugs like semaglutide, which can be made chemically or biologically. The government is aiming to fix loopholes where the same molecule got dual licensing under different rules. New mandatory labelling will specify the origin as 'synthetic' or 'r-DNA-origin'. This move aligns India's framework with global standards for better traceability. π§ͺ